The diabetic patient has a substantially increased in-hospital mortality after acute myocardial infarction, which is around twice that of non-diabetic subjects. A number of interventions can substantially improve this outcome. The use of thrombolytic therapy reduces case fatality proportionately to
Managing the diabetic patient with acute myocardial infarction
โ Scribed by Fisken, R.A.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 54 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0742-3071
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The benefits of thrombolytic therapy in a patient with diabetes having a myocardial infarction are now well accepted but this treatment may be withheld inappropriately because of concerns about retinal haemorrhage. We therefore examined whether junior doctors alter their use of thrombolysis for the
We examined hemostatic abnormalities in 23 patients with acute myocardial infarction (AMI), 10 with pulmonary embolism (PE), and 10 with deep vein thrombosis (DVT). At the onset of AMI, plasma levels of tissue-type plasminogen activator (t-PA), PA inhibitor-I (PAI-I), fibrin-D-dimer, thrombin-antith
We report the case of a patient who developed an acute anteroseptal and inferior myocardial infarction during dobutamine stress echocardiography. The proposed mechanism for this event is discussed based on results obtained during emergency coronary angioplasty and subsequent clinical findings.